Clinical Thyroidology^® for the Public

Volume 19

Clinical Thyroidology^® for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association^®.

In this issue Volume 19 Issue 2, the studies ask the following questions:

• Can we predict who will require levothyroxine after a partial thyroidectomy/ lobectomy?
• Is T3 safe for treating hypothyroidism?
• Can AI prevent unnecessary thyroid biopsies?
• Does thyroid cancer that occurs during childhood behave differently than in adults?
• Does radioactive iodine help thyroid cancer patients live longer?
• What is Nanosecond Pulse Field Ablation and is it effective to treat benign thyroid nodules?

In this issue Volume 19 Issue 1, the studies ask the following questions:

• What is the best treatment option for hyperthyroidism?
• Is block-and-replace therapy coming back for treatment of Graves’ disease?
• Is removing only the thyroid isthmus enough for some thyroid cancers?
• Can a standard protocol decrease the risk of low calcium levels after surgery?
• Is there a new test that can help diagnose medullary thyroid cancer?
• What is my risk of getting thyroid cancer if I have a thyroid cancerassociated gene?

Clinical Thyroidology^® for the Public Past Issues

2014 – 2025

2011 – 2013

2008 – 2010

Editor
Alan P. Farwell, MD, FACE
Boston Medical Center
Boston University Chobanian & Avedisian School of Medicine

Editorial Board
Gary Bloom, New York, NY
Maria Brito, MD, Dallas, TX
Susana Ebner, MD, Boston, MA
Alina Gavrila, MD, MMSC, Boston, MA
Poorani Goundan, MD, San Francisco
Sun Lee, MD, Boston, MA
Joanna Miragaya, MD, Atlanta, GA
Jason D. Prescott, MD PhD, New York, NY
Marjorie Safran, MD, Worcester, MA
Phillip Segal, MD, Toronto, ON, Canada
Vibhavasu Sharma, MD, Albany, NY
Pinar Smith, MD, Chicago, IL
Ebru Sulanc, MD , Detroit, MI
Whitney Woodmansee, MD, Gainesville, FL

Follow @thyroidfriends